a16z Podcast: The Economics of Expensive Medicines
The a16z Show30 Mai 2019

a16z Podcast: The Economics of Expensive Medicines

with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio)

The advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold before. In this episode, MIT economist Andrew Lo and a16z General Partner on the Bio Fund Jorge Conde discuss how exactly we place an economic value on a cure; the questions we still need to figure out, like who should pay for what and how; and how we need to start thinking about handling the coming influx of highly priced medicines like these into our healthcare system.

If we think about these payments as a kind of 'mortgage for a cure,' what happens when your gene therapy mortgage defaults? How would payment plans like these move between insurance plans? Lo and Conde also discuss the broader context in our healthcare system, the economics and risk of drug discovery and development overall – and finally, how our markets might just function more like biological systems than anything else.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(1000)

Patrick Collison on Stripe’s Early Choices, Smalltalk, and What Comes After Coding

Patrick Collison on Stripe’s Early Choices, Smalltalk, and What Comes After Coding

Michael Truell, CEO of Cursor, sits down with Patrick Collison, CEO of Stripe and an investor in Anysphere, to talk about Collison's history with Smalltalk and Lisp, the MongoDB and Ruby decisions Str...

20 Feb 52min

AI’s Capital Flywheel: Models, Money, and the Future of Power

AI’s Capital Flywheel: Models, Money, and the Future of Power

a16z's Martin Casado and Sarah Wang join Latent Space hosts Alessio Fanelli and Swyx to discuss what makes this AI investment cycle unlike anything in the history of venture capital. They cover why th...

19 Feb 57min

From Copilots to Agents: Rebuilding the Company Around AI

From Copilots to Agents: Rebuilding the Company Around AI

a16z's Angela Strange and Gabriel Vasquez speak with Carlos García Ottati, founder and CEO of Kavak, about building Latin America's largest online used car marketplace across Mexico, Brazil, Chile, Ar...

18 Feb 59min

WSJ x a16z: The Next 25 Years of Defense Innovation

WSJ x a16z: The Next 25 Years of Defense Innovation

In this episode from WSJ Invest Live, Andy Serwer speaks with Katherine Boyle, general partner at a16z, about the American Dynamism practice she helped launch four years ago. They discuss why saying "...

17 Feb 30min

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

a16z general partner Jorge Conde talks with Vasant Narasimhan, CEO of Novartis International, about transforming a 250-year-old conglomerate into a pure play medicines company and unlocking $180 billi...

16 Feb 58min

Balaji and Dan Wang: The Engineering State vs Lawyerly State

Balaji and Dan Wang: The Engineering State vs Lawyerly State

Balaji Srinivasan speaks with Dan Wang, author of Breakneck, about China's industrial rise, America's competing strengths in software and finance, and what happens when an engineering state and a lawy...

13 Feb 1h 3min

Anish Acharya: Is SaaS Dead in a World of AI?

Anish Acharya: Is SaaS Dead in a World of AI?

In this episode from 20VC, Harry Stebbings talks with Anish Acharya, general partner at a16z, about the future of SaaS in an AI world. Anish argues that software is completely oversold and that the ge...

12 Feb 1h 21min

How Magic Johnson Built a Billion-Dollar Portfolio in 30 Years

How Magic Johnson Built a Billion-Dollar Portfolio in 30 Years

a16z’s Chris Lyons speaks with Earvin "Magic" Johnson about his 30-year journey from athlete to billionaire businessman. They cover the art of deal-making, lessons from mentors Michael Ovitz and Dr. J...

11 Feb 1h 5min

Populært innen Business og økonomi

lydartikler-fra-aftenposten
stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengepodden-2
pengesnakk
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
utbytte
stormkast-med-valebrokk-stordalen
morgenkaffen-med-finansavisen
rss-politisk-preik
liberal-halvtime
rss-markedspuls-2
rss-sunn-okonomi
lederpodden
rss-pa-konto